Search
for
Sort by
Research 30 of 81
- Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
- Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: A survey-based study
- PCOS and Obesity: Contraception Challenges
- FERTILITY-SPARING MANAGEMENT OF ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA & ENDOMETRIAL CANCER: A COMPARISON OF THE LEVONORGESTREL-RELEASING INTRAUTERINE DEVICE VS SYSTEMIC THERAPY
- Sessualità e sindrome dell’ovaio policistico
- Abstracts from the 2024 WDS Forum - virtual option
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Contraceptive use in acne
- Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception
- Venous thromboembolism and women's health
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Treatment of hyperandrogenism in women
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function
- Complications of Subcutaneous Contraception: A Review
- Hair cortisol/cortisone in combined oral contraceptive users: An exploratory analysis
- The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial
- Vitamin D and the Skin: A Review for Dermatologists
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Molecular interactions of natural and synthetic steroids in female hamsters’ flank organs
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats
- Epidemiological Assessment of Testosterone Levels in Women Population: A Factorial Analysis of Cell Proliferation
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- Case Study: Hereditary Cancer Genetic Testing in Unaffected Patients May Allow for Early Intervention and Aggressive Management